Lidocaine-tetracaine topical has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetotoxicity following administration of up to 6.6 times the human dose. There are no controlled data in human pregnancy. Lidocaine-tetracaine topical is only recommended for use during pregnancy when benefit outweighs risk.

See references

Lidocaine is excreted into human milk. There are no data on the excretion of tetracaine into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering lidocaine-tetracaine topical to nursing women.

See references